Literature DB >> 8957608

Differentiating benign from malignant lung lesions using "quantitative" parameters of FDG PET images.

K F Hübner1, E Buonocore, H R Gould, J Thie, G T Smith, S Stephens, J Dickey.   

Abstract

UNLABELLED: Fluorine-18 labeled deoxyglucose positron-emission tomography (FDG-PET) applications in oncology include the differential diagnosis of chest masses and single pulmonary nodules. However, FDG is not tumor-specific; rather, it also accumulates in inflammatory processes. This study was performed to identify image parameters that would improve the specificity of PET.
METHODS: Twenty-six patients who had benign and malignant lung lesions were examined retrospectively. Positron-emission tomography data were acquired in dynamic scanning mode after intravenous bolus of 250-402 MBq of FDG. Standardized uptake values (SUVs) were calculated and Patlak analyses were performed in selected regions of interest in the PET images. Positron-emission tomography results were related to histological diagnosis (N = 49) or clinical follow-up (N = 3).
RESULTS: The specificity and sensitivity of the original PET scan reports, which was based on visual image interpretation and loosely applied SUVs, was 100% and 73%, respectively. Using the SUVs with a cut-off value of 3.8 and Kpat value with a cut-off at 0.025 min-1 improved the specificity to 81% and 85%.
CONCLUSION: FDG-PET image interpretation can be facilitated by using SUV information or the accumulation rate of the radiotracer (Patlak). With additional validation, this method could have a significant cost-effective impact on the medical/surgical management of chest masses.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8957608     DOI: 10.1097/00003072-199612000-00005

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  23 in total

1.  Comments on characterization of solitary pulmonary nodules with 18F-FDG PET/CT relative activity distribution analysis.

Authors:  Orazio Schillaci; Ferdinando F Calabria
Journal:  J Thorac Dis       Date:  2015-10       Impact factor: 2.895

2.  Effects of ROI definition and reconstruction method on quantitative outcome and applicability in a response monitoring trial.

Authors:  Nanda C Krak; R Boellaard; Otto S Hoekstra; Jos W R Twisk; Corneline J Hoekstra; Adriaan A Lammertsma
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-10-15       Impact factor: 9.236

3.  The value of delayed (18)F FDG-PET imaging in diagnosis of solitary pulmonary nodules: A preliminary study on 28 patients.

Authors:  Peng Yang; Xiao-Yang Xu; Xiao-Jing Liu; Jing-Shan Gong
Journal:  Quant Imaging Med Surg       Date:  2011-12

4.  Kikuchi-Fujimoto disease mimicking malignant lymphoma with 2-[(18)F]fluoro-2-deoxy-D-glucose PET/CT in children.

Authors:  Ji Eun Kim; Eun Kyung Lee; Jae Min Lee; Soon Hwan Bae; Kwang Hae Choi; Young Hwan Lee; Jeong Ok Hah; Joon Hyuk Choi; Eun Jung Kong; Ihn Ho Cho
Journal:  Korean J Pediatr       Date:  2014-05-31

5.  Additional value of integrated PET-CT in the detection and characterization of lung metastases: correlation with CT alone and PET alone.

Authors:  W De Wever; L Meylaerts; L De Ceuninck; S Stroobants; J A Verschakelen
Journal:  Eur Radiol       Date:  2006-10-03       Impact factor: 5.315

6.  Positron emission tomography in the evaluation of pulmonary nodules among patients living in a coccidioidal endemic region.

Authors:  Nathaniel Reyes; Oluwole O Onadeko; Maria Del Carmen Luraschi-Monjagatta; Kenneth S Knox; Margaret A Rennels; Travis Kent Walsh; Neil M Ampel
Journal:  Lung       Date:  2014-05-07       Impact factor: 2.584

7.  Performance of integrated FDG-PET/CT for differentiating benign and malignant lung lesions--results from a large prospective clinical trial.

Authors:  Sandra Pauls; Andreas K Buck; Gisela Halter; Felix M Mottaghy; Rainer Muche; Christina Bluemel; Susanne Gerstner; Stefan Krüger; Gerhard Glatting; Ludger Sunder-Plassmann; Peter Möller; Hans-Jürgen Brambs; Sven N Reske
Journal:  Mol Imaging Biol       Date:  2008-01-16       Impact factor: 3.488

8.  Dual-time-point FDG-PET/CT for the detection of hepatic metastases.

Authors:  Albert Dirisamer; Benjamin S Halpern; Wolfgang Schima; Martin Heinisch; Florian Wolf; Mohsen Beheshti; Franz Dirisamer; Michael Weber; Werner Langsteger
Journal:  Mol Imaging Biol       Date:  2008-08-16       Impact factor: 3.488

9.  Does the availability of positron emission tomography modify diagnostic strategies for solitary pulmonary nodules? An observational study in France.

Authors:  Irawati Lemonnier; Cédric Baumann; Nicolas Jay; Kazem Alzahouri; Patrick Arveux; Damien Jolly; Catherine Lejeune; Michel Velten; Fabien Vitry; Marie-Christine Woronoff-Lemsi; Francis Guillemin
Journal:  BMC Cancer       Date:  2009-05-11       Impact factor: 4.430

10.  Abnormal 18F-FDG Uptake Detected with Positron Emission Tomography in a Patient with Breast Cancer: A Case of Sarcoidosis and Review of the Literature.

Authors:  Selmin Ataergin; Nuri Arslan; Ahmet Ozet; Mehmet Ali Ozguven
Journal:  Case Rep Med       Date:  2009-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.